Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2005 Aug 10;53(16):6254-61.
doi: 10.1021/jf050536+.

Composition, stability, and bioavailability of garlic products used in a clinical trial

Larry D Lawson  1 , Christopher D Gardner
Affiliations

Composition, stability, and bioavailability of garlic products used in a clinical trial

Larry D Lawson et al. J Agric Food Chem. .

Abstract

In support of a new clinical trial designed to compare the effects of crushed fresh garlic and two types of garlic supplement tablets (enteric-coated dried fresh garlic and dried aged garlic extract) on serum lipids, the three garlic products have been characterized for (a) composition (14 sulfur and 2 non-sulfur compounds), (b) stability of suspected active compounds, and (c) availability of allyl thiosulfinates (mainly allicin) under both simulated gastrointestinal (tablet dissolution) conditions and in vivo. The allyl thiosulfinates of blended fresh garlic were stable for at least 2 years when stored at -80 degrees C. The dissolution release of thiosulfinates from the enteric-coated garlic tablets was found to be >95%. The bioavailability of allyl thiosulfinates from these tablets, measured as breath allyl methyl sulfide, was found to be complete and equivalent to that of crushed fresh garlic. S-Allylcysteine was stable for 12 months at ambient temperature. The stability of the suspected active compounds under the conditions of the study and the bioavailability of allyl thiosulfinates from the dried garlic supplement have validated the use of these preparations for comparison in a clinical trial.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Structures and formation of compounds analyzed
See this image and copyright information in PMC

References

    1. Ackermann R, Mulrow C, Ramirez G, Gardner C, Morbidoni L, Lawrence V. Garlic shows promise for improving some cardiovascular risk factors. Arch.Intern.Med. 2001;161:813–824. - PubMed
    1. Lawson LD, Wang ZJ, Papadimitriou D. Allicin release under simulated gastrointestinal conditions from garlic powder tablets employed in clinical trials on serum cholesterol. Planta Med. 2001;67:13–18. - PubMed
    1. Neil HAW, Silagy CA, Lancaster T, Hodgeman J, Vos K, Moore JW, Jones L, Cahill J, Fowler G. Garlic powder in the treatment of moderate hyperlipidaemia: a controlled trial and meta-analysis. J.Roy.Coll.Physicians London. 1996;30:329–334. - PMC - PubMed
    1. Stevinson C, Pittler MH, Ernst E. Garlic for treating hypercholesterolemia: a meta-analysis of randomized clinical trials. Ann.Intern.Med. 2000;133:420–429. - PubMed
    1. Alder R, Lookinland S, Berry JA, Williams M. A systematic review of the effectiveness of garlic as an anti-hyperlipidemic agent. J.Am.Acad.Nurse Practitioners. 2003;15:120–129. - PubMed

Publication types